Value Sense
BHG
Bright Health Group, Inc. (BHG)
Last Price$8.20.0%
Market Cap$65.5M
LTM Selling, General & Administrative Expenses (SG&A)
$260.0M
YoY Growth
-55.5%
3Y CAGR
-5.6%
5Y CAGR
+38.3%
Stock quality & Intrinsic value
5/10
463.3% undervalued
BHG
is 463.3% undervalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

Bright Health Group, Inc. Selling, General & Administrative Expenses (SG&A)

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Selling, General & Administrative Expenses (SG&A)
$81.2M
$153.9M
$308.7M
$914.1M
$584.2M
$0.0
BHG
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for BHG and see if it's the right time to invest.
Dive in

Bright Health Group, Inc. (BHG) Selling, General & Administrative Expenses (SG&A) comparison analysis

General

LTM Selling, General & Administrative Expenses (SG&A)

Growth

Company name

YoY growth

3Y CAGR

5Y CAGR

Bright Health Group, Inc. logo
Bright Health Group, Inc.BHG
$260.0M
(55.5%)
(5.6%)
N/A
Median Peer Set
$2,249.1M
0.0%
2.4%
0.0%
UnitedHealth Group Incorporated logo
UnitedHealth Group IncorporatedUNH
$26.8B
N/A
N/A
N/A
Cigna Corporation logo
Cigna CorporationCI
$14.8B
2.7%
4.8%
2.2%
Centene Corporation logo
Centene CorporationCNC
$12.4B
(1.3%)
6.8%
13.7%
Humana Inc. logo
Humana Inc.HUM
$6,093.0M
(51.7%)
(15.6%)
(3.6%)
Molina Healthcare, Inc. logo
Molina Healthcare, Inc.MOH
$2,743.0M
11.4%
9.9%
16.2%
Oscar Health, Inc. logo
Oscar Health, Inc.OSCR
$1,755.2M
416.7%
87.9%
N/A
Alignment Healthcare, Inc. logo
Alignment Healthcare, Inc.ALHC
$371.4M
20.8%
8.5%
N/A
Clover Health Investments, Corp. logo
Clover Health Investments, Corp.CLOV
$291.2M
(34.8%)
(13.2%)
9.5%
Elevance Health Inc. logo
Elevance Health Inc.ELV
$0.0
N/A
N/A
N/A
CVS Health Corporation logo
CVS Health CorporationCVS
($10.0M)
N/A
N/A
N/A

BHG key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Revenue
% growth
130.6
0.0%
280.7
114.9%
1,207.3
330.2%
4,029.4
233.7%
2,412.0
(40.1%)
1,160.8
(51.9%)
Cost of Goods Sold (COGS)96.4224.41,047.33,953.72,206.21,283.7
Gross Profit
% margin
34.2
26.2%
56.3
20.1%
160.0
13.3%
75.7
1.9%
205.8
8.5%
(122.9)
(10.6%)
Operating Expenses96.9181.6417.61,273.9682.51,737.8
Research & Development Expenses (R&D)2.57.219.40.00.00.0
Selling, General & Administrative Expenses (SG&A)81.2153.9308.7914.1584.20.0
Operating Income
% margin
(62.6)
(48.0%)
(125.3)
(44.7%)
(257.6)
(21.3%)
(1,198.2)
(29.7%)
(476.7)
(19.8%)
(627.7)
(54.1%)
Interest Income0.00.00.07.212.80.0
Interest Expense0.00.00.08.012.838.2
Pre-tax Income(62.6)(125.3)(257.6)(1,204.9)(634.3)(629.2)
Income Tax
% effective tax rate
3.5
(5.6%)
8.4
(6.7%)
(9.2)
3.6%
(26.5)
2.2%
3.7
(0.6%)
(1.4)
0.2%
Net Income
% margin
(62.6)
(48.0%)
(133.7)
(47.6%)
(248.4)
(20.6%)
(1,178.4)
(29.2%)
(638.0)
(26.4%)
(1,200.6)
(103.4%)
EPS(37.97)(79.52)(145.94)(240.33)(81.08)(150.94)
Diluted EPS(37.97)(79.52)(145.94)(240.33)(81.08)(150.94)
EBITDA
% margin
(61.6)
(47.2%)
(124.2)
(44.3%)
(249.3)
(20.7%)
(1,161.4)
(28.8%)
(425.3)
(17.6%)
(1,145.5)
(98.7%)

Discover more Stock Ideas

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
More ideas -->

FAQ

1) What is Bright Health Group, Inc.'s Selling, General & Administrative Expenses (SG&A)?

As of today, Bright Health Group, Inc.'s last 12-month Selling, General & Administrative Expenses (SG&A) is $260.0M, based on the financial report for Dec 31, 2023 (Q4’2023).

2) What is Bright Health Group, Inc.'s Selling, General & Administrative Expenses (SG&A) growth rate?

Over the last year, Bright Health Group, Inc.'s Selling, General & Administrative Expenses (SG&A) growth was (55.5%). The average annual Selling, General & Administrative Expenses (SG&A) growth rates for Bright Health Group, Inc. have been 32.1% over the past three years, 38.3% over the past five years.

3) Is Bright Health Group, Inc.'s Selling, General & Administrative Expenses (SG&A) growth rate Good?

Over the last year, Bright Health Group, Inc.'s Selling, General & Administrative Expenses (SG&A) growth was (55.5%), which is lower than industry growth of 1.7%. It indicates that Bright Health Group, Inc.'s Selling, General & Administrative Expenses (SG&A) growth is Good.

4) How does Bright Health Group, Inc.'s Selling, General & Administrative Expenses (SG&A) growth rate compare to its peers?

Over the last year, Bright Health Group, Inc.'s Selling, General & Administrative Expenses (SG&A) growth was (55.5%), which is lower than peer median growth of 472.1%. The list of peers includes UNH, CI, CNC, HUM, MOH, OSCR, ALHC, CLOV, ELV, CVS etc.